Discovery and characterization of potent thiazoles versus methicillin- and vancomycin-resistant Staphylococcus aureus

Journal of Medicinal Chemistry

Volumn 57, Issue 4, 2014, Pages 1609-1615

  Mohammad, Haroon ^a   Mayhoub, Abdelrahman S ^b,c   Ghafoor, Adil ^a   Soofi, Muhammad ^a   Alajlouni, Ruba A ^a   Cushman, Mark ^b   Seleem, Mohamed N ^a  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

^c Al Azhar University   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

THIAZOLE DERIVATIVE; VANCOMYCIN;

ANIMAL CELL; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; CYTOTOXICITY; DRUG METABOLISM; DRUG PENETRATION; DRUG POTENCY; DRUG SOLUBILITY; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; KINETICS; MAMMAL CELL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHYSICAL CHEMISTRY; STRUCTURE ACTIVITY RELATION; VANCOMYCIN RESISTANT STAPHYLOCOCCUS AUREUS;

DRUG DISCOVERY; DRUG RESISTANCE, MICROBIAL; MAGNETIC RESONANCE SPECTROSCOPY; METHICILLIN; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; STAPHYLOCOCCUS AUREUS; STRUCTURE-ACTIVITY RELATIONSHIP; THIAZOLES; VANCOMYCIN;

EID: 84896877673     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm401905m     Document Type: Article

References (17)

1. Moran, G. J.; Krishnadasan, A.; Gorwitz, R. J.; Fosheim, G. E.; McDougal, L. K.; Carey, R. B.; Talan, D. A., for the EMERGEncy ID Net Study Group. Methicillin-resistant S. aureus infections among patients in the emergency department N. Engl. J. Med. 2006, 355, 666-674
2. Fischbach, M. A.; Walsh, C. T. Antibiotics for emerging pathogens Science 2009, 325, 1089-1093
3. Hiramitsu, K. Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance Lancet Infect. Dis. 2001, 1, 147-155
4. Wilson, Peter; Andrews, J. A.; Charlesworth, R.; Walesby, R.; Singer, M.; Farrell, D. J.; Robbins, M. Linezolid resistance in clinical isolates of Staphylococcus aureus J. Antimicrob. Chemother. 2003, 51, 186-188
5. Hays, S. J.; Rice, M. J.; Ortwine, D. F.; Johnson, G.; Schwarz, R. D.; Boyd, D. K.; Copeland, L. F.; Vartanian, M. G.; Boxer, P. A. Substituted 2-benzothiazolamines as sodium flux inhibitors: quantitative structure-activity relationships and anticonvulsant activity J. Pharm. Sci. 1994, 83, 1425-1432
6. Das, J.; M., R.; Lin, J.; Liu, C.; Doweyko, A. M.; DeFex, H. F.; Fang, Q.; Pang, S.; Pitt, S.; Shen, D. R.; Schieven, G. L.; Barrish, J. C.; Wityak, J. Discovery of 2-amino-heteroaryl-benzothiazole-6-anilides as potent p56(lck) inhibitors Bioorg. Med. Chem. Lett. 2003, 13, 2587-2590
7. Hutchinson, I.; Bradshaw, T. D.; Matthews, C. S.; Stevens, M. F.; Westwell, A. D. Antitumour benzothiazoles. Part 20: 3′-Cyano and 3′-alkynyl-substituted 2-(4′-aminophenyl) benzothiazoles as new potent and selective analogues Bioorg. Med. Chem. Lett. 2003, 13, 471-474
8. Paget, C. J.; Kisner, K.; Stone, R. L.; DeLong, D. C. Heterocyclic substituted ureas. II. Immunosuppressive and antiviral activity of benzothiazolyl- and benzoxazolylureas J. Med. Chem. 1969, 12, 1016-1018
9. Shelke, S. H.; Mhaske, P. C.; Hande, P.; Bobade, V. D. Synthesis and antimicrobial activities of novel series of 1-((4-methyl-2-substituted thiazol-5-yl)methyleneam INO)-2-substituted isothiourea derivatives Phosphorus, Sulfur Silicon Relat. Elem. 2013, 188, 1262-1270
10. Shelke, S. H.; Mhaske, P. C.; Nandave, M.; Narkhade, S.; Walhekar, N. M.; Bobade, V. D. Synthesis and pharmacological evaluation of a novel series of 3-aryl-2-(2-substituted-4-methylthiazole-5-yl)thiazolidin-4-one as possible anti-inflammatory and antimicrobial agents Bioorg. Med. Chem. Lett. 2012, 22, 6373-6376
11. King, M. D.; Humphrey, B. J.; Wang, Y. F.; Kourbatova, E. V.; Ray, S. M.; Blumberg, H. M. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections Ann. Intern. Med. 2006, 144, 309-317
12. Johnson, J. K.; Khoie, T.; Shurland, S.; Kreisel, K.; Stine, O. C.; Roghmann, M.-C. Skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus USA300 clone Emerging Infect. Dis. 2007, 13, 1195-1200
13. Deresinski, S. Vancomycin in combination with other antibiotics for the treatment of serious methicillin-resistant Staphylococcus aureus infections Clin. Infect. Dis. 2009, 49, 1072-1079
14. Singh, S. R.; Bacon, A. E.; Young, D. C.; Couch, K. A. In vitro 24-h time-kill studies of vancomycin and linezolid in combination versus methicillin-resistant Staphylococcus aureus Antimicrob. Agents Chemother. 2009, 53, 4495-4497
15. Kerns, E. H; Di, L. Drug-like Properties: Concepts, Structure Design and Methods from ADME to Toxicity Optimization; Elsevier Inc.: Burlington, MA, 2008; pp 287-296.
16. Mayhoub, A. S.; Khaliq, M.; Botting, C.; Li, Z.; Kuhn, R. J.; Cushman, M. An investigation of phenylthiazole antiflaviviral agents Bioorg. Med. Chem. 2011, 19, 3845-3854
17. Ohler, E.; Elbadawi, M.; Zbiral, E. Dialkyl (1,2-epoxy-3-oxoalkyl) phosphonates as synthons for heterocyclic carbonyl-compounds: synthesis of acyl-substituted thiazoles, indolizines, imidazo[1,2-alpha]pyridines and imidazo[1,2-alpha]pyrimidines Chem. Ber./Recl. 1985, 118, 4099-4130 Diseases